Product for Out-Licensing
- Overview
- Product Profile
Eurand Minitabs® Nifedipine (once-daily)
Eurand's Nifedipine is a sustained-release calcium antagonist product
indicated for prophylaxis of chronic and stable angina and treatment of hypertension.
This proprietary Nifedipine formulation combines the simplicity of tablet formulation with the sophistication of multiparticulate systems in a convenient once-daily therapy.
Therapeutic Category |
Cardiovascular |
Indication |
|
Development Status |
Commercialized; Licensing opportunities available |
Available Dosage |
|
Product Description |
Sustained-release (once-daily) formulation of nifedipine |
Eurand Technology |
Eurand Minitabs® - Customized Drug Release technology |
Licensing Opportunities |
Eurand is seeking licensing partners for global opportunities. |
This information is provided solely for the purpose of the evaluation of business opportunities by potential collaboration partners. The information is based on currently existing data and marketing authorizations in a number of jurisdictions and should not be assumed to be approved by regulatory authorities in any individual country. Consumers should consult with their individual physician for product information and should not rely upon any information provided here.
For more information on this product, please contact Eurand.
Contact Us
Click here to request moreinformation on Eurand's
Products for Out-Licensing